Skip to main content

BRCA testing in metastatic castration-resistant prostate cancer: successes and troubles in a real world setting. An Italian Multicentric study.

Tommasi S, Barberis M, Caniglia A, Pilato B, Zito FA, Carosi M, Melucci E, Casini B, Russo A, Gismondi V, Cirmena G, Paudice M, Malapelle U, Pepe F, Troncone G, Fontanini G, Bruno R, Faviana P, Vacirca D, Taormina SV, Francesconi S, Caprera C, Corsi M, Bracarda S, Coppola CA

Publication: Pathologica (2024) • Vol 116 • Page 303-309PMID: 39748712View on PubMed

Purpose

This paper compared the DNA yield, DNA integrity and next-generation sequencing (NGS) success and mutation detection among unmatched formalin-fixed paraffin-embedded (FFPE) prostate cancer specimens that were stored for <3 years, 3-5 years or >5 years (not specified if storage was as blocks or macrodissected tumor). The specimens included 217 prostatectomy and 24 core needle biopsies that were collected and analyzed at seven different sites. 

Conclusion

The median DNA concentration was 11.45 ng/µL, with 32 specimens (including 16 of the 24 biopsies) yielding concentrations below the threshold (2 ng/µL). ANOVA revealed a significant negative effect of FFPE storage duration on DNA concentration (P=0.0006). The DNA concentration decreased from 21.14 ng/µL in the specimens stored for <3 years to 13.12 ng/µL and 8.24 ng/µL in specimens stored for 3-5 years and > 5 years, respectively. DNA integrity numbers were <2 (very degraded) for 70.5% of specimens (132/187), and 24% of specimens had a DIN of 2-5 (45/187). The median FFPE storage duration was longer for specimens with DIN <2 than for those with DIN of 2-5 (4 vs 2.9 years; P=0.006).  Overall BRCA1/2 status was “evaluable” in 90% (217 of 241) of the specimens by next-generation sequencing.  The percentage of specimens that were “not evaluable” by NGS increased from 10.8% in FFPE specimens stored for <3 y, to 40% in FFPE specimens stored for 3-5 years and to 55% in FFPE specimens stored for >5 years (P<0.0001). Pathogenic BRCA1 mutations were found in 3 specimens and pathogenic BRCA2 mutations were found in 19 specimens; 9 of these specimens with pathogenic mutation(s) were stored <3 years, 9 were stored 3-5 years and 4 were stored >5 years.  Additionally, variants of uncertain significance were detected in 6 FFPE specimens: 3 specimens were stored <3 years and 3 were stored >5 years. The authors conclude that storage of FFPE tissue for >3 years can compromise DNA analysis.

Studies (1)

Purpose

This study compared the DNA yield, DNA integrity and next-generation sequencing (NGS) success and mutation detection among unmatched formalin-fixed paraffin-embedded (FFPE) prostate cancer specimens that were stored for <3 years, 3-5 years or >5 years (not specified if storage was as blocks or macrodissected tumor). The specimens included 217 prostatectomy and 24 core needle biopsies that were collected and analyzed at seven different sites.  This study included a total of 241 FFPE prostate cancer specimens (217 specimens were via prostatectomy and 24 specimens were core needle biopsies) that were collected and processed at seven different centers. Prostatectomy specimens were cut at 5 mm intervals along the coronal plane before fixation. All specimens were fixed in 10% neutral buffered formalin overnight to 96 h and embedded in paraffin. To identify the dominant tumor nodule, 4-5 µm sections were cut and H&E-stained and then the dominant tumor nodule was macrodissected from six or more unstained serial sections (median 50% tumor cells, range 20-80%). DNA was extracted at each center using their spin column-based or binding bead-based kit of choice (no further details provided). DNA was quantified using the Qubit dsDNA HS Assay Kit, and DNA integrity was evaluated using the Agilent Genomic DNA Screen Tape Assay. NGS sequencing was conducted using the Ion Chef System (no further details provided) and analyzed using Ion Reporter Analysis Software.

Summary of Findings

The median DNA concentration was 11.45 ng/µL, with 32 specimens (including 16 of the 24 biopsies) yielding concentrations below the threshold (2 ng/µL). ANOVA revealed a significant negative effect of FFPE storage duration on DNA concentration (P=0.0006). The DNA concentration decreased from 21.14 ng/µL in the specimens stored for <3 years to 13.12 ng/µL and 8.24 ng/µL in specimens stored for 3-5 years and > 5 years, respectively. DNA integrity numbers were <2 (very degraded) for 70.5% of specimens (132/187), and 24% of specimens had a DIN of 2-5 (45/187). The median FFPE storage duration was longer for specimens with DIN <2 than for those with DIN of 2-5 (4 vs 2.9 years; P=0.006).  Overall BRCA1/2 status was “evaluable” in 90% (217 of 241) of the specimens by next-generation sequencing.  The percentage of specimens that were “not evaluable” by NGS increased from 10.8% in FFPE specimens stored for <3 y, to 40% in FFPE specimens stored for 3-5 years and to 55% in FFPE specimens stored for >5 years (P<0.0001). Pathogenic BRCA1 mutations were found in 3 specimens and pathogenic BRCA2 mutations were found in 19 specimens; 9 of these specimens with pathogenic mutation(s) were stored <3 years, 9 were stored 3-5 years and 4 were stored >5 years.  Additionally, variants of uncertain significance were detected in 6 FFPE specimens: 3 specimens were stored <3 years and 3 were stored >5 years. The authors conclude that storage of FFPE tissue for >3 years can compromise DNA analysis.

  • Biospecimens

    TissueProstate
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNAFluorometry
    DNANext generation sequencing
    DNAAutomated electrophoresis/Bioanalyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionMethod of tissue acquisition
    Biopsy
    Surgical resection
    StorageStorage duration
    3-5 years
    <3 years
    >5 years
    Next generation sequencing SpecificTargeted nucleic acid
    BRCA1/2